Nutchapon Xanthavanij
Nutchapon Xanthavanij publishes mostly in Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism, on topics such as Diabetes Treatment and Management, Chemotherapy-induced cardiotoxicity and mitigation and Chronic Obstructive Pulmonary Disease (COPD) Research.
- World rank
- #1,773,358 of 7,710,434 ranked researchers
- Rank in United States
- #545,841 of 1,627,098
- Works
- 46
- Citations
- 183
- Citations per work
- 4.0
What does Nutchapon Xanthavanij research?
Nutchapon Xanthavanij's work is mostly in Medicine (48%), Environmental Science (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2248.2%
- Medicine2248.2%
- Everything else2146.7%
- Physical Sciences25.1%
- 1Pulmonary and Respiratory Medicine16% of their works
- 2Cardiology and Cardiovascular Medicine11% of their works
- 3Endocrinology, Diabetes and Metabolism9% of their works
- 4Oncology8% of their works
- 5Health, Toxicology and Mutagenesis5% of their works
- 6Physiology4% of their works
Research topics
- Diabetes Treatment and Management
- Chemotherapy-induced cardiotoxicity and mitigation
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Lung Cancer Diagnosis and Treatment
- Air Quality and Health Impacts
- Cancer Immunotherapy and Biomarkers
- Venous Thromboembolism Diagnosis and Management
- Metabolism, Diabetes, and Cancer
Which keywords describe Nutchapon Xanthavanij's research?
The keywords of their largest research topics: Chemotherapy, Cardiovascular Outcomes, Oxidative Stress, Type 2 Diabetes, Diagnosis, Anthracyclines, COPD and Doxorubicin.
- AMP-Activated Protein Kinase
- Antithrombotic Therapy
- PD-1 and PD-L1
- Air Pollution
- CT Screening
- Doxorubicin
- Anthracyclines
- Type 2 Diabetes
- Cardiovascular Outcomes
- Chemotherapy
- Oxidative Stress
- Diagnosis
- COPD
- spirometry
- Lung Cancer
- Immune Checkpoint Blockade
- Particulate Matter
- Venous Thromboembolism
- Metformin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Chemotherapy112 topics
- Cardiovascular Outcomes101 topic
- Oxidative Stress102 topics
- Type 2 Diabetes101 topic
- Diagnosis92 topics
- Anthracyclines61 topic
- COPD61 topic
- Doxorubicin61 topic
- spirometry61 topic
- CT Screening51 topic
- Lung Cancer51 topic
- Air Pollution41 topic
- Immune Checkpoint Blockade41 topic
- PD-1 and PD-L141 topic
- Particulate Matter41 topic
- Antithrombotic Therapy31 topic
- Venous Thromboembolism31 topic
- AMP-Activated Protein Kinase21 topic
- Metformin21 topic
Where does Nutchapon Xanthavanij work?
Nutchapon Xanthavanij's main affiliation in the publication record is Mount Auburn Hospital, United States.
How many publications and citations does Nutchapon Xanthavanij have?
OpenAlex counts 46 works and 183 citations for Nutchapon Xanthavanij, an h-index of 6, ranking #1,773,358 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nutchapon Xanthavanij. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.